Bioplastic material for chronic foot ulcers in patients with diabetes mellitus

In this article, we present the experience of using G-derm bioplastic material in the treatment of chronic ulcers in patients with neuropathic form of grade III -IV diabetic foot syndrome (DFS) (Wagner classification). This study included 64 patients. The control group comprised 33 patients who received standard treatment with hydrocolloid dressings. In the experimental group, which included 31 patients, we administered bioplastic material G-derm in addition to standard therapy. Patients’ condition was evaluated on days 1,10, 30, and 45 from the moment of treatment initiation. The use of bioplastic material G-derm in DFS patients significantly reduced the area and depth of the wound after 45 days. We also used a device developed by us that facilitates the process of measuring the area and depth of a chronic wound. In addition to that, we used special devices for wound dressing developed by us in the experimental group. They ensured good attachment of the bioplastic material to the wound surface and made wound dressing less time- and labor-consuming.